Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

NCT00489372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Healthy, no Evidence of Disease

Interventions

DRUG: Se-methyl-seleno-L-cysteine
OTHER: placebo
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)